Skip to main content

News

30 May, 2018 Vancouver lights up for World Preeclampsia Day May 22 2018
May 22 is World Preeclampsia Day, which aims to bring awareness to the relatively high prevalence and devastating impact of pre-eclampsia and other hypertensive disorders of pregnancy. Approximately one in ten women who are pregnant for the first time develop pre-eclampsia and it is a leading cause of maternal and infant death, with approximately 46,000 maternal deaths and 2... Read More
11 May, 2018 World Preeclampsia Day May 22
Walk around the city of Vancouver, BC, Canada on May 22 evening and you may notice that some iconic buildings lit up in orange. We are very excited to announce that BC Place, Vancouver City Hall, Vancouver Convention Centre and Science World will be joining us on our commitment to women’s health and raising awareness for pre-eclampsia by lighting up orange on World... Read More
27 Mar, 2018 Objective 3: Community Level Interventions for Pre-eclampsia (Update from February-March 2018)
Community Level Interventions for Pre-eclampsia (CLIP)  The writing of the CLIP primary results is ongoing, and a number of abstracts are being submitted to upcoming international conferences in fall. Ancillary studies for CLIP are underway. Data analysis for healthcare worker evaluation is being conducted in all the three sites, and data collection for economic... Read More
26 Mar, 2018 Objective 2: Health economics update (Feburary-March 2018)
Health Economics: Mozambique site visit- Asif Khowaja Asif Khowaja arrived in Maputo on February 18th for a week-long visit at the CISM centre in Manhica. During his visit, he trained 4 data collectors on the qualitative focus groups to explore perspective on the societal costs related to the CLIP interventions. Additionally, two nurses were trained on collecting costs of... Read More
26 Mar, 2018 Objective 4: Global Pregnancy Collaboration update (February to March 2018)
Global Pregnancy Collaboration (CoLab) Our ongoing activities are progressing well. We are working on a new effort with PATH, which will involve testing a new assay they are developing for a preeclampsia analyte, adipsin. We are collaborating on this proposal, which was funded by the 2017 Saving Lives at Birth. Preparations are underway to have urine samples analyzed from... Read More
26 Mar, 2018 Objective 1: CAP Study Update (February-March 2018)
The CAP Study Women with a history of pre-eclampsia in their most recent pregnancy who agreed to participate, received calcium 500mg daily or placebo from enrolment until they become pregnant, and up to 20 weeks of pregnancy.  All women received calcium 1500mg daily after 20 weeks as per WHO recommendations. The primary outcome is pre-eclampsia.  CAP study... Read More
23 Mar, 2018 Objective 2: miniPIERS and fullPIERs Update (February - March 2018)
In February, Dr. Beth Payne had the opportunity to visit Accra, Ghana for a week with the UMC Utrecht Global Health program. Beth has been collaborating with colleagues from Ghana and the Netherlands to develop the study protocol for “Severe Pre-eclampsia Adverse Outcome (SPOT) score for Triage of women with Pre-eclampsia Remote from Term: Validation and Development of a Risk... Read More
29 Jan, 2018 Objective 4: Global Pregnancy Collaboration update (Nov 2017 - Jan 2018)
During the Global Pregnancy Collaboration (CoLab) 2017 annual meeting, we reviewed our 2016 activities, planned how to continue our ongoing activities and—most importantly—established new directions for the upcoming year. Our workshop this year, entitled “Periconceptional and Pregnancy Nutrition: Role in Adverse Pregnancy Outcomes,” stimulated projects for the upcoming year.... Read More
29 Jan, 2018 Objective 1: CAP study update (Nov 2017 - Jan 2018)
The CAP Study Women with a history of pre-eclampsia in their most recent pregnancy who agreed to participate, received calcium 500mg daily or placebo from enrolment until they become pregnant, and up to 20 weeks of pregnancy.  All women received calcium 1500mg daily after 20 weeks as per WHO recommendations. The primary outcome is pre-eclampsia.    CAP... Read More
31 Oct, 2017 Congratulations to Samina on defending her Masters' thesis!
We are delighted to report the successful defence by Ms. Samin Bakhtawar for her thesis "Risk factors for sepsis among postpartum women admitted to tertiary care hospital Karachi, Pakistan: A nested case control study". Samina has earned a MSc in Epidemiology and Biostatistics at Aga Khan University for completion of this project, supervised by PRE-EMPT members: Dr. Sana... Read More

Pages